DCR3 locus is a predictive marker for 5-fluorouracil-based adjuvant chemotherapy in colorectal cancer

This publication has 12 references indexed in Scilit:

• Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster
  Proceedings of the National Academy of Sciences, 2000
• Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients
  British Journal of Cancer, 2000
• Genetic Prognostic Markers for Colorectal Cancer
  New England Journal of Medicine, 2000
• Adjuvant therapy of colon cancer
  CA: A Cancer Journal for Clinicians, 1999
• Chromosome arm 20q gains and other genomic alterations in colorectal cancer metastatic to liver, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization
  Genes, Chromosomes and Cancer, 1999
• Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer
  Nature, 1998
• Update on adjuvant treatment of colorectal cancer
  Current Opinion in Oncology, 1998
• Tissue microarrays for high-throughput molecular profiling of tumor specimens
  Nature Medicine, 1998
• Long-term results of single course of adjuvant intraportal chemotherapy for colorectal cancer
  The Lancet, 1995
• p53 mutations in colorectal cancer.
  Proceedings of the National Academy of Sciences, 1990